Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.

Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE Jr, Collard HR.

Eur Respir J. 2010 Jun;35(6):1322-8. doi: 10.1183/09031936.00092309. Epub 2009 Dec 8.

2.

IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.

Cho HJ, Hayashi T, Datta SK, Takabayashi K, Van Uden JH, Horner A, Corr M, Raz E.

J Immunol. 2002 May 15;168(10):4907-13.

3.

Type I interferon is required to mount an adaptive response to immunostimulatory DNA.

Van Uden JH, Tran CH, Carson DA, Raz E.

Eur J Immunol. 2001 Nov;31(11):3281-90.

4.

Enhancement of innate immunity against Mycobacterium avium infection by immunostimulatory DNA is mediated by indoleamine 2,3-dioxygenase.

Hayashi T, Rao SP, Takabayashi K, Van Uden JH, Kornbluth RS, Baird SM, Taylor MW, Carson DA, Catanzaro A, Raz E.

Infect Immun. 2001 Oct;69(10):6156-64.

5.

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites.

Horner AA, Datta SK, Takabayashi K, Belyakov IM, Hayashi T, Cinman N, Nguyen MD, Van Uden JH, Berzofsky JA, Richman DD, Raz E.

J Immunol. 2001 Aug 1;167(3):1584-91.

6.

DNA-based immunotherapeutics for the treatment of allergic disease.

Horner AA, Van Uden JH, Zubeldia JM, Broide D, Raz E.

Immunol Rev. 2001 Feb;179:102-18. Review.

PMID:
11292014
7.

Immunostimulatory DNA sequences : an overview.

Van Uden JH, Raz E.

Methods Mol Med. 2000;29:145-68. doi: 10.1385/1-59259-688-6:145.

PMID:
21374317
8.

DNA immunotherapeutics: new potential treatment modalities for allergic disease.

Goodman JS, Van Uden JH, Kobayashi H, Broide D, Raz E.

Int Arch Allergy Immunol. 1998 Jul;116(3):177-87. Review.

PMID:
9693265

Supplemental Content

Loading ...
Support Center